Extracellular matrix-degrading proteinases in the nervous system.
about
Matrix Metalloproteinase 9 Facilitates West Nile Virus Entry into the BrainNeuroserpin regulates neurite outgrowth in nerve growth factor-treated PC12 cellsRole of the aspartyl-asparaginyl-beta-hydroxylase gene in neuroblastoma cell motilityIL-1 beta induces proMMP-9 expression via c-Src-dependent PDGFR/PI3K/Akt/p300 cascade in rat brain astrocytesDoxycycline treatment decreases morbidity and mortality of murine neurocysticercosis: evidence for reduction of apoptosis and matrix metalloproteinase activity.Neuroserpin is expressed in the pituitary and adrenal glands and induces the extension of neurite-like processes in AtT-20 cells.Mononuclear phagocyte differentiation, activation, and viral infection regulate matrix metalloproteinase expression: implications for human immunodeficiency virus type 1-associated dementiaEthanol inhibition of aspartyl-asparaginyl-beta-hydroxylase in fetal alcohol spectrum disorder: potential link to the impairments in central nervous system neuronal migration.Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes.Cauda equina-derived extracellular matrix for fabrication of nanostructured hybrid scaffolds applied to neural tissue engineering.Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states.Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 3: brain tumor invasiveness.The Influence of Differentially Expressed Tissue-Type Plasminogen Activator in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis.A metalloprotease activity from C6 glioma cells inactivates the myelin-associated neurite growth inhibitors and can be neutralized by antibodies.The potential use of MMP inhibitors to treat CNS diseases.Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.Cerebrospinal fluid activity of tissue plasminogen activator in patients with neurological diseasesThe role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomasThe Molecular Mechanisms that Promote Edema After Intracerebral Hemorrhage.Candesartan reduces the hemorrhage associated with delayed tissue plasminogen activator treatment in rat embolic stroke.ATP increases the migration of microglia across the brain endothelial cell monolayer.Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis.Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy.Characterization of a cysteine proteinase inhibitor induced during neuronal cell differentiation.Cytokines and matrix metalloproteinases in the cerebrospinal fluid of patients with acute transverse myelitis: an outcome analysis.Glioma invasion in the central nervous system.Sulfur mustard-stimulated proteases and their inhibitors in a cultured normal human epidermal keratinocytes model: A potential approach for anti-vesicant drug development.The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cellsA Cannabinoid Receptor 2 Agonist Prevents Thrombin-Induced Blood-Brain Barrier Damage via the Inhibition of Microglial Activation and Matrix Metalloproteinase Expression in Rats.Characterization of downstream Ras signals that induce alternative protease-dependent invasive phenotypes.N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-beta relesase and reduces migration and invasiveness of human malignant glioma cells.Production, regulation and role of nitric oxide in glial cells.In vitro evaluation of reactive astrocyte migration, a component of tissue remodeling in glaucomatous optic nerve head.Molecular characterization of cell substratum attachments in human glial tumors relates to prognostic features.Delayed post-ischaemic administration of xenon reduces brain damage in a rat model of global ischaemia.Galectin-3 and galectin-3-binding site expression in human adult astrocytic tumours and related angiogenesis.Efficacy of curcumin therapy against Angiostrongylus cantonensis-induced eosinophilic meningitis.Site-specific immune regulation in the brain: differential modulation of major histocompatibility complex (MHC) proteins in brainstem vs. hippocampus.Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro.The therapeutic effect of (DL)-3-n-butylphthalide in rats with chronic cerebral hypoperfusion through downregulation of amyloid precursor protein and matrix metalloproteinase-2.
P2860
Q27486919-AD98D4B4-39DE-4977-8E59-8683E39CB700Q28204532-5E34418F-6ADA-4580-BEB8-4B9FB06DA2EEQ28214662-749CCB23-04B3-42A6-B3EC-E8EE69E86762Q28574764-F68DA2FE-C32C-40D4-8888-5B887817DCA8Q30489096-551B78F9-BB2D-4170-97F2-41E0ADE583B6Q30833796-E798055C-B3E8-4465-A10B-23A2D67E935CQ33843573-9328CADC-367C-4DB5-B6F0-11C33EBDBFECQ33944605-10454EC8-9810-4256-9E92-DE65B89DD664Q34392185-39F2CC5A-3E92-47EA-95F7-55FC38C39DBEQ35167234-5380233F-D851-4263-BF41-E87B73134BB7Q35765041-B7EBA027-7935-4E3B-AAFA-5CD2347DD0CBQ35918449-59081ACB-F814-4ABC-8B71-A2FE9687BFF4Q36079853-0DDD886F-2D6A-40DC-B852-E7A6A2952EC2Q36115903-36452AFD-4694-4B98-B4D5-9647432DFC4EQ36181275-FE68EB7C-0F16-4509-9A32-73A840AA6978Q36991072-F62B4A9E-66A1-47EA-B06D-6025590E8A09Q37219105-B01A0977-7B38-4221-9E8A-B67D222BF3C1Q38136195-5F7E3780-A052-4A2A-AF47-F97C449FF6B6Q38170064-70F2DFF8-A151-4F5F-9FA3-149AD2299775Q38592712-B7F5BAD5-CF12-4ED2-AEDE-F73767009BD2Q38789606-1915F722-2477-44D3-8952-0221D9DDF15EQ39762254-53E6CCD7-AD50-40B5-A6A7-CF7FD90D4E71Q40706939-05D41E39-FA53-4CB3-B280-743B9FB9B868Q40725030-564F6CD9-8468-4676-A8C4-C08E96CFF462Q41095945-3A211AE6-95E8-47E3-B12A-732A634EBB9EQ41131785-5A120FDE-7ED2-4EF8-BF21-8432A3980F33Q41679523-0BDF9E34-2FEA-414F-86B5-EA2FD0FEFDD8Q42139022-E4F2487B-F29E-4449-9035-6D57C71039E3Q42482446-FDED630C-276B-4AA7-A3A7-3D69A800090EQ42529175-7E54F115-39A1-45C7-92AC-BA52C69DAAF8Q42828380-0CB971E1-C0E9-496F-A97E-A265490E2834Q42981988-CEB9878A-CCF1-4AD1-BC60-4C51DE1574B9Q43592546-71489FC5-32F1-476D-9F2E-DD1E61AE6384Q43825689-B7015EE2-CA0A-49A9-8E7F-62ED2251EE5EQ47930576-8D5B8EB7-1C76-417D-95FC-C4EBB8F4269AQ48119227-1A43AADB-DDED-48E1-B254-0F76E768BCFEQ48230390-791FA03F-5F84-4C0A-93D6-41EE50714399Q48263245-34136AC6-A947-46AD-AD98-290BD309DB66Q48274687-FCAC7842-2CB2-445D-B850-9011CCCC6A3AQ48404367-DEE07E05-E57B-4D73-8720-DA8A10BC50B7
P2860
Extracellular matrix-degrading proteinases in the nervous system.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Extracellular matrix-degrading proteinases in the nervous system.
@en
type
label
Extracellular matrix-degrading proteinases in the nervous system.
@en
prefLabel
Extracellular matrix-degrading proteinases in the nervous system.
@en
P2860
P1433
P1476
Extracellular matrix-degrading proteinases in the nervous system.
@en
P2093
P2860
P304
P356
10.1111/J.1750-3639.1994.TB00825.X
P577
1994-04-01T00:00:00Z